{"id":"fde8a57e-a258-44e2-8ea3-60d6387a4eed","arxiv_id":"2608.09103","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":6.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":9,"one_line_summary":"Bayesian ACCESS jointly models suppressed small counts, autoregressive trends, change points, and state clustering to recover latent U.S. opioid mortality trajectories by race from 1999 to 2024.","lead":"This paper proposes a Bayesian model that infers hidden opioid overdose mortality trends and the years when those trends changed, using CDC data where small death counts are suppressed for privacy. If it works, public health analysts could track rare-outcome epidemics in subgroups where most of the signal is hidden.","discovery_kind":"new_method","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Model change points are shared across racial groups, so the abstract's 'subgroup-specific structural changes' is unsupported by the model structure.","rationale":"The reader's weakest assumption concerned the first-order identity-link AR structure and its sensitivity to higher-order lags or smooth regime changes. That is a legitimate misspecification concern, but it is acknowledged in Section 5 and can be viewed as a modeling choice. The more load-bearing internal inconsistency is that the model's change-point structure is shared across demographic groups by construction, while the abstract explicitly promises 'subgroup-specific ... structural changes.' This is not a matter of simulation evidence or prior strength; it is a direct mismatch between the central claim and the model architecture. The model can produce subgroup-specific trajectories (because η_k and ζ_k differ), but all demographic groups within a state share the same change-point timing, so 'subgroup-specific structural changes' is not identifiable. This concern does not invalidate the entire method—state-level change-point detection and suppression-aware inference may still be valuable—but it means the abstract overstates the findings. The reader's CONDITIONAL verdict already requires revisions; this concern adds a specific required revision: either temper the claim to 'state-level structural changes with demographic-specific magnitudes' or extend the model to allow group-specific change points. Hence I do not change the verdict, but I identify a different and, in my view, more concrete load-bearing issue. Credit is due for the coherent suppression-aware likelihood and the sanity check in Figure 4, where model-based national rates track observed national rates, but that agreement does not bear on group-specific structural-change identification.","tokens_in":15241,"tokens_out":7799,"duration_ms":92473,"concrete_test":"Simulate 51 states × 4 racial groups over 26 years from the same observation model, but inject a genuine change point at t=2019 only for the Black group (e.g., increase in the innovation parameter for that group) while holding other groups' dynamics constant. Fit Bayesian ACCESS with the stated hyperparameters and examine the posterior change-point probability for that state. Because the model has no group-specific change-point parameter, the posterior probability at 2019 will be pulled toward a shared change point for all groups, and the probability conditional on race cannot differ. An analytic demonstration would be to show that the model's likelihood is invariant to relabeling change points across demographic groups, implying no group-specific structural-change inference is identifiable.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim (Abstract) states that Bayesian ACCESS identifies 'distinct subgroup-specific epidemic trajectories and structural changes.' However, the model in Section 3.2–3.4 defines λ_ikt = η_k α_it + ζ_k β_it λ_ik(t−1), where α_it and β_it are piecewise-constant, cluster-level, state-specific autoregressive parameters, and η_k, ζ_k are demographic multipliers that are constant over time. Consequently, any change point in α_it or β_it alters the dynamics of every racial group in a given state simultaneously; there is no parameter, prior, or likelihood term that permits group-specific change-point timing. The posterior change-point probability p_i(t|D) defined in Section 3.6 is a state-level quantity, and the paper's Figures 3–4 report only state or national aggregated probabilities, never race-specific change-point probabilities. Thus the abstract's 'subgroup-specific ... structural changes' is not a quantity the model can estimate. If the true opioid epidemic has race-specific structural breaks (e.g., the fentanyl wave differentially affecting Black populations), the model will either miss these breaks entirely or smear them across all groups. The Discussion (Section 5) lists higher-order lags and cross-demographic dependence as future work but does not flag the absence of group-specific change points, so this overstatement is unacknowledged.","agreement_with_reader":"disagree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper proposes Bayesian ACCESS, a hierarchical Bayesian model for latent mortality-rate trajectories and change points from count time series subject to small-cell suppression, and applies it to U.S. state-level opioid-related overdose mortality counts from CDC WONDER, 1999–2024. The model uses an identity-link first-order autoregressive specification for the latent rate, with piecewise-constant cluster-specific AR parameters, multiplicative demographic effects, a mixture-of-finite-mixtures prior on state clustering, and a suppression-aware observation model. The application reports posterior trajectories, change-point probabilities, racial-group multiplier estimates, and 2025–2026 predictions, together with national-level aggregation checks.","tokens_in":15636,"tokens_out":4046,"duration_ms":48483,"significance":"If validated, the methodological contribution would be useful: directly modeling the suppression mechanism rather than imputing suppressed cells, jointly inferring change points and clustering, and propagating suppression uncertainty into latent-rate estimates are sensible and practically important goals for public-health surveillance. The paper is also strong in assembling a plausible hierarchical model in NIMBLE, applying it to a highly policy-relevant dataset, and reporting posterior uncertainty throughout. However, the central claims that the method 'accurately captures' latent trajectories and that the analysis identifies 'subgroup-specific structural changes' are not supported by the current evidence: the model has no race-specific change-point parameters, the national fit is an in-sample diagnostic on data used for hyperparameter calibration, and the 2025–2026 predictions are deterministic recursions of fitted AR parameters. These issues are fixable through rewording and additional validation, but they are load-bearing for the paper's stated contributions.","major_comments":[{"comment":"The abstract's claim of 'distinct subgroup-specific epidemic trajectories and structural changes' is not supported by the model structure. In Eq. (3), λ_ikt = η_k α_it + ζ_k β_it λ_ik(t−1), the demographic multipliers η_k and ζ_k are constant over time, while the change points and segment-specific parameters α_it and β_it are shared across all racial groups within a state or cluster. Consequently, the model cannot estimate race-specific change-point timing; the posterior change-point probability p_i(t|D) defined in §3.6 is a state-level quantity, and Figures 3–4 report only state- or national-level probabilities. Section 5 lists higher-order lags and cross-demographic lags as future work but does not acknowledge that the current model's structural changes are demographic-group-invariant. The abstract and Section 4 wording should be revised to say the model captures subgroup-specific rate levels and trends, not subgroup-specific structural changes.","section":"Abstract; §3.2–§3.3; §4"},{"comment":"The predictive and validation claims are not backed by out-of-sample evidence. The 2025–2026 predictions are computed by recursively applying the fitted AR parameters as λ_ik(T+h) = α_ikT + β_ikT λ_ik(T+h−1), assuming no additional change point after T; they are therefore in-sample projections of the fitted model rather than independent forecasts. The national-level agreement in Figure 4 compares the population-weighted posterior fit to directly observed national rates from the same CDC WONDER data used to set the hyperparameters in §3.5; this is a fit diagnostic, not a validation of latent-trajectory recovery. Since Section 5 states that 'extensive numerical studies' demonstrate accuracy, those studies should be reported in the main text, or the claims should be explicitly limited to description of the fitted model. A simulation study with known latent trajectories and suppression would be needed to support the statement that Bayesian ACCESS 'accurately captures' latent trajectories and change points.","section":"§3.6; §4; §5"},{"comment":"The hyperparameters are calibrated using 'empirical scale information from the CDC WONDER opioid-related overdose mortality data' (e.g., σ_α = 10^-5, (a_λ, b_λ) = (−10, 2), and the tight prior (μ_η, σ_η) = (0, 0.1)). Because the same data are then used for model comparison (WAIC) and for the national fit assessment, the reported fit statistics may be optimistically biased, and the posterior change-point probabilities may be sensitive to this data-informed prior specification. The paper should report a sensitivity analysis over plausible hyperparameter ranges, or at least discuss the potential circularity of using the same data for prior calibration and model fit evaluation.","section":"§3.5; §4"},{"comment":"The change-point prior truncates L(g) at L_max = 4 and imposes d_min = 2 for T = 26 years. This restricts each series to at most five segments and at most one change point per two-year interval. For the opioid epidemic, which has multiple waves, this may be reasonable, but the paper does not assess sensitivity to L_max and d_min, and the posterior probabilities in Figure 3 could change materially if the prior allowed more change points or shorter segments. A brief sensitivity check would strengthen the claim that the detected change-point patterns are data-driven rather than artifacts of the truncation bounds.","section":"§3.4.2; §3.5"}],"minor_comments":[{"comment":"The opening paragraph of Section 5 in the provided full text runs words together ('Inthisarticle, weintroducedbayesianACCESS'); please correct the typographical spacing.","section":"§5"},{"comment":"The lower panel of Figure 3 shows state-level posterior change-point probabilities. Because the model assigns the same change-point configuration to all racial groups within a state, the figure labels should state explicitly that the displayed probabilities are state-level and shared across racial groups, to avoid misleading readers into interpreting them as race-specific.","section":"Figure 3; §3.6"},{"comment":"The identifiability constraint η_1 = ζ_1 = 1 is introduced in Eq. (3) and Section 3.4.4. It would be helpful to state clearly that the reference-group choice changes the interpretation of η_k and ζ_k and that the posterior distributions of these multipliers are relative to the White group.","section":"§3.2"},{"comment":"The WAIC comparison (28,130.4 vs. 402,220.2) is reported without the effective number of parameters or Monte Carlo standard errors. Adding this information would help readers judge whether the negative binomial model's advantage is well resolved.","section":"§4"},{"comment":"The paper uses 'unreliable' counts (those between 10 and 19) as observed data. Since these counts are flagged by CDC WONDER as unreliable, a brief discussion of how this unreliability is handled in the observation model (or a sensitivity check treating them as censored) would be useful.","section":"§2; §4"}],"recommendation":"major_revision","confidential_remarks":null},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Bayesian ACCESS is a genuinely useful integration of existing pieces: a suppression-aware observation model, identity-link autoregressive rates, multiple change points, and MFM clustering in one Bayesian hierarchy. The state-race application to CDC WONDER opioid mortality is the most convincing part—suppression is widespread for AIAN and Asian/PI groups, and the model yields interpretable parameters while propagating suppression uncertainty into trajectories and change-point probabilities. The national population-weighted aggregation tracks directly observed national rates well (Figure 4), and Figure 3 shows sensible state-level heterogeneity in change-point evidence.\n\nThat said, the stress-test note lands. In Equation (3), the demographic multipliers η_k and ζ_k are time-invariant; the change points live in the shared α_it and β_it. So all racial groups in a given state or cluster share the same change-point timing. The abstract's claim of \"distinct subgroup-specific epidemic trajectories and structural changes\" is therefore misleading—trajectories are subgroup-specific, but structural changes are not. The Discussion does not flag this, and it should. It is a moderate overstatement, not a fatal flaw, but it needs correcting.\n\nThe bigger gap is validation. The main text contains no simulation study demonstrating that the posterior change-point probabilities and latent rates recover known truth under suppression. The supplementary materials are referenced but not included, and the data-informed priors, while reasonable, are not a substitute for a known-truth check. The 2025–2026 predictions are deterministic recursions of fitted AR parameters, so they are not an independent out-of-sample test; Figure 4's agreement uses the same vital statistics the model was fit to. The paper is otherwise honest—Section 5 openly lists first-order lag and the lack of cross-demographic dependence as limitations—so this is a soundness gap rather than a suggestion of hidden problems.\n\nWho should read this: statisticians working with suppressed public-health counts, and epidemiologists studying race-specific overdose trends. It would be a good journal paper after a revision that adds a simulation study, releases code and convergence diagnostics, and either corrects the abstract or extends the model to allow group-specific change points. I would not cite it yet, but I would send it to a serious referee.","headline":"A useful integrated framework, but the abstract overclaims subgroup-specific change points, and the lack of simulation means the accuracy claim is unproven.","tokens_in":16124,"tokens_out":2138,"would_cite":false,"duration_ms":25385,"reading_group":"yes","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":["62F15","62M10","62P10"],"pacs":[],"model":"deepseek-v4-flash","headline":"Bayesian ACCESS recovers latent opioid mortality trajectories from suppressed CDC WONDER counts.","keywords":["latent epidemic trajectories","change-point detection","count time series","data suppression","Bayesian hierarchical model","opioid overdose mortality","CDC WONDER","mixture of finite mixtures"],"falsifier":"Compare the model's posterior intervals for selected state-race trajectories against restricted-use unsuppressed death counts; if the intervals systematically miss the true counts, or if the observed 2025 and 2026 national rates fall outside the model's predictive intervals once released, the central claim fails.","tokens_in":15029,"feed_emoji":"📉","tokens_out":10396,"duration_ms":104619,"temperature":0.7,"pith_summary":"Opioid-related overdose mortality in the U.S. is usually studied from CDC WONDER counts that suppress any state-race-year cell with 1–9 deaths, which hides exactly the small populations that often carry the highest burden. This paper argues that those suppressed series still contain enough information to infer the latent epidemic trajectory and its structural breaks, provided the suppression rule is put inside the statistical model rather than treated as a missing-data nuisance. The proposed Bayesian ACCESS model does this with a suppression-aware count likelihood, an identity-link autoregressive rate equation with piecewise-constant coefficients, and a clustering prior that lets states share information while keeping group-specific dynamics. Fitted to 1999–2024 data, the model finds a late-period break consistent with the recent national overdose-death decline and reveals distinct trajectories by race, including a much larger innovation component for Black populations. A sympathetic reader should take the paper's central claim to be that publicly released suppressed statistics can support valid subgroup-level epidemic inference, not merely count recovery.","feed_headline":"Model infers opioid death trends despite suppressed CDC counts","feed_subtitle":"It finds state- and race-specific turning points, including the recent decline, that raw public data hide.","key_machinery":"The load-bearing object is the identity-link autoregressive rate equation $$\\lambda_{ikt} = \\eta_k\\alpha_{it} + \\zeta_k\\beta_{it}\\lambda_{ik(t-1)},$$ adapted from integer-valued GARCH count models to multivariate suppressed series. The innovation $\\alpha_{it}$ and persistence $\\beta_{it}$ are assumed constant within each temporal segment for each cluster of states, so $\\beta<1$ gives geometric settling toward a plateau, $\\beta=1$ gives linear growth, and $\\beta>1$ gives exponential growth; the model then infers both the number and location of the segments. A mixture-of-finite-mixtures prior on the unknown partition of states, together with a truncated-Poisson prior on the number of change points per cluster and a uniform prior over admissible break locations, lets the model learn the clustering and break structure rather than fixing them. A collapsed Gibbs sampler for cluster assignments and adaptive Metropolis updates for continuous parameters, with parallel tempering, make the multimodal posterior tractable. The machinery's defining move is that the known suppression set $S$ enters the observation model directly, so a suppressed cell is not an imputation target but a constraint on the latent count.","core_discovery":"On its own terms, the paper's discovery is that the latent mortality rate for state $i$, race $k$, and year $t$ can be written as $\\lambda_{ikt} = \\eta_k \\alpha_{it} + \\zeta_k \\beta_{it} \\lambda_{ik(t-1)}$, with $\\alpha_{it}$ and $\\beta_{it}$ piecewise constant within unknown segments that are shared by clustered states, and $\\eta_k,\\zeta_k$ race-specific multipliers. Conditioning the observed counts on the known suppression set $S=\\{1,\\ldots,9\\}$ turns every suppressed cell into a likelihood term that sums over the possible hidden counts, so uncertainty from suppression flows directly into the posterior distributions of the latent rates and change points. The paper demonstrates the claim by showing that population-weighted posterior national rates track directly observed national rates closely, by reporting state-specific posterior change-point probabilities (strong evidence around 2018 in California, Texas, and Massachusetts; around 2015 in Missouri and Tennessee), and by estimating racial multipliers such as $\\eta_{\\text{Black}} \\approx 3.43$ for the innovation component. It also reports posterior-predictive declines from 2024 to 2026 of roughly 30–40 percent across racial groups, with wide state variation. If the central claim is right, the posterior change-point probabilities are reliable summaries of when the epidemic's regime changed, including the 2023–2024 decline.","pith_inferences":["If the first-order autoregressive assumption holds, the posterior change-point probability at the end of a series can be read as an early-warning signal: a spike near the final observed year flags a regime shift before it is confirmed by later data. The paper does not propose this surveillance use, but its forecasting recursion makes it a direct extension.","The large Black innovation multiplier suggests that year-to-year changes in Black overdose mortality are driven mostly by new shocks rather than persistence of the previous year's rate; an untested implication is that forecasting for this group should weight leading indicators of new drug-market shocks more heavily than extrapolated trends.","Because the model clusters states by temporal dynamics rather than geography, the estimated clusters may correspond to policy or drug-supply regimes rather than Census regions; this could be checked by comparing cluster membership against state-level policy timing and fentanyl-seizure data.","Treating suppression as a known support constraint rather than an imputation problem may transfer to other disclosure mechanisms, such as noise-infused or differentially private counts, as long as the released value's relationship to the latent count is known; a testable adaptation would replace the suppression likelihood with the appropriate privacy mechanism."],"forward_implications":["Posterior change-point probabilities computed from suppressed state-race counts can be treated as evidence about when the epidemic's dynamics changed, so public CDC WONDER files can support structural-break surveillance without restricted-use data.","Population-weighted aggregation of the posterior state-level rates reproduces the directly observed national rates, meaning national monitoring can be built from subgroup-level suppressed series rather than relying on unsuppressed national tabulations.","The model's predictive distributions place 2026 rates roughly 30–40 percent below 2024 levels for all racial groups, with West Virginia and Kentucky among the largest predicted declines and Iowa and Wyoming among the smallest; these are testable forecasts.","The estimated racial multipliers imply distinct dynamics: Black populations have a much larger innovation component, while Asian/Pacific Islander populations have lower innovation and weaker autoregressive persistence, so a single national trend curve misrepresents the epidemic.","Because the observation model is generic to count suppression, the same framework can be applied to other suppressed public-health count systems, such as cancer incidence, infectious-disease surveillance, and maternal health."],"supporting_citations":[{"why":"Documents the CDC WONDER small-cell suppression rule and its effect on local mortality rates, motivating the suppression-aware observation model.","marker":"Tiwari et al. (2014)"},{"why":"Shows Bayesian spatial modeling of suppressed CDC WONDER mortality counts, the direct precedent this paper generalizes to autoregressive change-point settings.","marker":"Quick (2019)"},{"why":"Supplies the mixture-of-finite-mixtures prior that lets the number of state clusters be learned rather than fixed.","marker":"Miller & Harrison (2018)"},{"why":"Provides the integer-valued GARCH autoregressive count specification that the identity-link rate model adapts.","marker":"Ferland et al. (2006)"},{"why":"Contributes the endemic–epidemic intercept-plus-autoregressive decomposition for multivariate surveillance counts used in the rate equation.","marker":"Held et al. (2005)"},{"why":"Provides the Bayesian change-point clustering framework for state-level mortality curves, including the uniform prior over admissible change-point configurations.","marker":"Dass et al. (2015)"},{"why":"Supplies spike-and-slab change-point methodology and the minimum-spacing prior used to avoid nearly coincident breaks.","marker":"Cappello et al. (2023)"},{"why":"Provides the collapsed Gibbs sampler algorithm adapted for posterior sampling of cluster assignments under the MFM prior.","marker":"Neal (2000)"},{"why":"Supplies the synthetic-opioid wave interpretation used to explain the mid-to-late 2010s structural shifts identified by the model.","marker":"Ciccarone (2019)"},{"why":"Provides the external surveillance evidence of the recent overdose-mortality decline used to interpret the late-period change point.","marker":"Friedman et al. (2026a)"}],"fun_headline_variants":["Bayesian model uncovers opioid mortality trends from suppressed counts","Suppressed CDC data still reveal opioid death turning points","Bayesian ACCESS maps state and race trajectories in opioid epidemic","Hidden opioid mortality patterns exposed by Bayesian approach","Model extracts opioid trend signal from censored CDC counts"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The model's identification rests on the assumption that each race-state latent rate follows a first-order autoregression whose coefficients are constant within a few abrupt segments shared by all states in a cluster; if the true dynamics include longer memory, dependence on past observed counts, or smooth rather than abrupt regime changes, the estimated break years and trajectories are not guaranteed to recover the truth.","fun_headline_variants_meta":{"raw":{"variants":["Bayesian model uncovers opioid mortality trends from suppressed counts","Suppressed CDC data still reveal opioid death turning points","Bayesian ACCESS maps state and race trajectories in opioid epidemic","Hidden opioid mortality patterns exposed by Bayesian approach","Model extracts opioid trend signal from censored CDC counts"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000627,"raw_usage":{"total_tokens":2961,"prompt_tokens":1068,"completion_tokens":1893,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":684,"completion_tokens_details":{"reasoning_tokens":1817}},"tokens_in":684,"tokens_out":1893,"duration_ms":14569,"temperature":1.0,"reasoning_tokens":1817,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-11T23:30:11.325312+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Compare the model's posterior intervals for selected state-race trajectories against restricted-use unsuppressed death counts; if the intervals systematically miss the true counts, or if the observed 2025 and 2026 national rates fall outside the model's predictive intervals once released, the central claim fails.","supporting_citations":[],"review_version":1}